Abstract
We present and examine the efficacy of a novel benzoxepin-based scaffold for modulation of the human estrogen receptor. Receptor tolerance of this new molecular scaffold is examined through presentation of experimentally determined antiproliferative effects on human MCF-7 breast tumor cells and measured binding affinities. The effect of functional group substitution on the benzoxepin scaffold is explored through a brief computational structure-activity relationship investigation with molecular simulation.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Benzoxepins / chemical synthesis*
-
Benzoxepins / chemistry
-
Benzoxepins / pharmacology
-
Cell Line, Tumor
-
Estrogen Receptor Modulators / chemical synthesis*
-
Estrogen Receptor Modulators / chemistry
-
Estrogen Receptor Modulators / pharmacology
-
Humans
-
Inhibitory Concentration 50
-
Models, Molecular
-
Receptors, Estrogen / chemistry
-
Receptors, Estrogen / drug effects*
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Benzoxepins
-
Estrogen Receptor Modulators
-
Receptors, Estrogen